Preparation of novel anthranilic acids as antibacterial agents: Extensive evaluation of structural and physical properties on antibacterial activity and human serum albumin affinity
摘要:
In the past few years a significant effort has been devoted by Pharmacia toward the discovery of novel antibiotics. We have recently described the identification of an anthranilic acid lead 1 and the optimization resulting in the advanced lead 2. In this report, we describe the preparation of several selected analogs to probe the dependency of this template for antibacterial activity and the affinity these compounds have for human serum albumin (HSA). These analogs illustrate that decreased affinity for HSA can be achieved while retaining relevant antibacterial activity. The most important factor for reduced HSA affinity is decrease in log P rather than a structural change. (C) 2007 Elsevier Ltd. All rights reserved.
The invention provides antimicrobial agents and methods of using the agents for sterilization, sanitation, antisepsis, disinfection, and treatment of infections in mammals.
这项发明提供了抗菌剂和使用这些剂进行哺乳动物的消毒、卫生、防腐、消毒和治疗感染的方法。
Antibacterial agents
申请人:Thorarensen Atli
公开号:US20050113450A1
公开(公告)日:2005-05-26
The present invention relates to antibacterial agents that are useful for sterilization, sanitation, antisepsis, and disinfection
本发明涉及用于杀菌、卫生、消毒和消毒的抗菌剂。
Antibacterial benzoic acid derivatives
申请人:——
公开号:US20040110802A1
公开(公告)日:2004-06-10
The invention provides antimicrobial agents and methods of using the agents for sterilization, sanitation, antisepsis, disinfection, and treatment of infections in mammals.
Preparation of novel antibacterial agents. Replacement of the central aromatic ring with heterocycles
作者:Jianke Li、Brian D. Wakefield、J. Craig Ruble、Cory M. Stiff、Donna L. Romero、Keith R. Marotti、Michael T. Sweeney、Gary E. Zurenko、Douglas C. Rohrer、Atli Thorarensen
DOI:10.1016/j.bmcl.2006.12.055
日期:2007.4
Discovery of novel antibacterial agents is a significant challenge. We have recently reported on our discovery of novel antibacterial agents in which we have rapidly optimized potency utilizing a parallel chemistry approach. These advanced leads suffer from high affinity for human serum albumin (HSA). In an effort to decrease the affinity for HSA we have prepared a series of heterocyclic analogs, which